Want to join the conversation?
$AMP 2Q15 Call: 2Q15-end excess capital was $2.5Bil. Risk-based capital ratio is estimated to be approx. 560%. Returned $549MM to shareholders through share repurchase and dividends, which is the highest quarterly level, equating to 125% operating earnings.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.